
Keywords: AHR; aryl hydrocarbon receptor; BBB; blood-brain barrier; CNS; central nervous system; CIS; clinically isolated syndrome; EDSS; expanded disability status scale; EAE; experimental autoimmune encephalomyelitis; DC; dendritic cell; DMF; dimethyl fumarate; D